Table 1.

Ischemic stroke cases genotyped as part of the SiGN study and previously genotyped control groups, according to study site^*.

Site	Location	Genotype platform	Cases (n)	Controls (n)
CASES GENOTYPED THROUGH SiGN (US SITES)
GASROS	Boston, USA	Illumina HumanOmni 5M Exome	470
GCNKSS	Greater Cincinnati region, USA	Illumina HumanOmni 5M Exome	499
ISGS	Multi-center, USA	Illumina HumanOmni 5M Exome	187
MCISS	New Jersey, USA	Illumina HumanOmni 5M Exome	630
MIAMISR	Miami, USA	Illumina HumanOmni 5M Exome	299
NHS	National sample, USA	Illumina HumanOmni 5M Exome	316
NOMAS(S)	Manhattan, USA	Illumina HumanOmni 5M Exome	363
REGARDS	National sample, USA	Illumina HumanOmni 5M Exome	311
SPS3	Multi-center; USA; Latin America, Spain	Illumina HumanOmni 5M Exome	962
SWISS	Multi-center, USA	Illumina HumanOmni 5M Exome	271
WHI	National sample, USA	Illumina HumanOmni 5M Exome	458
WUSTL	St. Louis, USA	Illumina HumanOmni 5M Exome	455
CASES GENOTYPED THROUGH SiGN (INTERNATIONAL SITES)
BASICMAR	Barcelona, Spain	Illumina HumanOmni 5M Exome	930
BRAINS	London, England	Illumina HumanOmni 5M Exome	114
GRAZ	Graz, Austria	Illumina HumanOmni 5M Exome	639
KRAKOW	Krakow, Poland	Illumina HumanOmni 5M Exome	952	776
LEUVEN	Leuven, Belgium	Illumina HumanOmni 5M Exome	482	468
LUND	Lund, Sweden	Illumina HumanOmni 5M Exome	651
SAHLSIS	Gothenburg, Sweden	Illumina HumanOmni 5M Exome	800
PREVIOUSLY GENOTYPED CONTROL GROUPS
HABC	Multi-center, USA	Illumina 1M-Duo		2802
HRS	Multi-center, USA	Illumina HumanOmni 2.5M		12507
OAI	Multi-center, USA	Illumina HumanOmni 2.5M		4011
ADHD	Barcelona, Spain	Illumina HumanOmni 1M		435
GRAZ	Graz, Austria	Illumina 610		829
INMA	Barcelona, Spain	Illumina HumanOmni 1M		1061
KORA	Southern Germany	Illumina Human 550		820
WTCCC	United Kingdom	Illumina 660		5186

^*SiGN cases genotyped at the Center for Inherited Diseases (CIDR) on the Illumina HumanOmni 5M Exome array.